Mirum Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Mirum Pharmaceuticals, Inc. (MIRM) reported Increase (Decrease) in Prepaid Expense and Other Assets of $7.71 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $1.08M, a 73.46% decline year-over-year.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $6.63M, a 118.88% increase year-over-year.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$5.99M.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $4.63M, a 33.60% increase year-over-year.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $5.76M, a 577.97% increase from fiscal 2024.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $849.00K, a 76.42% decline from fiscal 2023.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $3.60M, a 2.07% decline from fiscal 2022.
- Mirum Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.68M, a 8.31% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 8 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.71M 10-Q · filed 2026-08-05 | $1.72M derived: sum of 3 quarters · filed 2026-08-05 | $6.36M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $6.63M 10-Q · filed 2026-05-06 | $640.00K derived: sum of 2 quarters · filed 2026-05-06 | $5.27M derived: sum of 3 quarters · filed 2026-05-06 | $9.36M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.36M derived: sum of 2 quarters · filed 2026-02-25 | $2.73M derived: sum of 3 quarters · filed 2026-08-05 | $5.76M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $4.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $8.72M derived: sum of 2 quarters · filed 2026-08-05 | $11.75M 10-Q · filed 2025-11-04 | $11.47M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.11M 10-Q · filed 2026-08-05 | $6.84M derived: sum of 3 quarters · filed 2026-08-05 | $10.31M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $3.03M 10-Q · filed 2026-05-06 | $2.76M derived: sum of 2 quarters · filed 2026-05-06 | $6.22M derived: sum of 3 quarters · filed 2026-05-06 | $4.80M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $3.19M derived: sum of 2 quarters · filed 2026-02-25 | $1.77M derived: sum of 3 quarters · filed 2026-02-25 | $849.00K 10-K · filed 2026-02-25 | |
| 2024-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.04M derived: sum of 2 quarters · filed 2025-11-04 | $1.12M 10-Q · filed 2025-11-04 | $1.27M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | -$1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$2.35M 10-Q · filed 2025-08-06 | -$2.19M derived: sum of 3 quarters · filed 2026-02-25 | $473.00K derived: sum of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | -$918.00K 10-Q · filed 2025-05-07 | -$765.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.90M derived: sum of 3 quarters · filed 2026-02-25 | $2.64M derived: sum of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.82M derived: sum of 2 quarters · filed 2026-02-25 | $3.56M derived: sum of 3 quarters · filed 2026-02-25 | $3.60M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $2.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.41M derived: sum of 2 quarters · filed 2024-11-12 | $3.45M 10-Q · filed 2024-11-12 | $5.46M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $742.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $782.00K 10-Q · filed 2024-08-07 | $2.80M derived: sum of 3 quarters · filed 2025-02-26 | $5.95M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | $40.00K 10-Q · filed 2024-05-08 | $2.06M derived: sum of 2 quarters · filed 2025-02-26 | $5.21M derived: sum of 3 quarters · filed 2025-02-26 | $3.08M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $5.17M derived: sum of 2 quarters · filed 2025-02-26 | $3.04M derived: sum of 3 quarters · filed 2025-02-26 | $3.68M 10-K · filed 2025-02-26 | |
| 2022-09-30 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.02M derived: sum of 2 quarters · filed 2023-11-02 | $1.66M 10-Q · filed 2023-11-02 | $3.43M derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$1.49M 10-Q · filed 2023-08-07 | $275.00K derived: sum of 3 quarters · filed 2024-03-15 | $2.62M derived: sum of 4 quarters · filed 2024-03-15 | |
| 2022-03-31 | $637.00K 10-Q · filed 2023-05-04 | $2.40M derived: sum of 2 quarters · filed 2024-03-15 | $4.75M derived: sum of 3 quarters · filed 2024-03-15 | $4.53M derived: sum of 4 quarters · filed 2024-03-15 | |
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $4.11M derived: sum of 2 quarters · filed 2024-03-15 | $3.90M derived: sum of 3 quarters · filed 2024-03-15 | $4.01M 10-K · filed 2024-03-15 | |
| 2021-09-30 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.13M derived: sum of 2 quarters · filed 2022-11-09 | $2.24M 10-Q · filed 2022-11-09 | $2.37M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$103.00K 10-Q · filed 2022-08-04 | $25.00K derived: sum of 3 quarters · filed 2022-08-04 | $1.69M derived: sum of 4 quarters · filed 2022-08-04 | |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-05 | $240.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.90M derived: sum of 3 quarters · filed 2022-05-05 | $1.78M derived: sum of 4 quarters · filed 2022-05-05 | |
| 2020-12-31 | $128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $1.79M derived: sum of 2 quarters · filed 2022-03-09 | $1.67M derived: sum of 3 quarters · filed 2022-03-09 | $1.83M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.54M derived: sum of 2 quarters · filed 2021-11-15 | $1.70M 10-Q · filed 2021-11-15 | $1.34M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | -$122.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $36.00K 10-Q · filed 2021-08-05 | -$319.00K derived: sum of 3 quarters · filed 2021-08-05 | $2.07M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $158.00K 10-Q · filed 2021-05-06 | -$197.00K derived: sum of 2 quarters · filed 2021-05-06 | $2.19M derived: sum of 3 quarters · filed 2021-05-06 | $2.60M derived: sum of 4 quarters · filed 2021-05-06 | |
| 2019-12-31 | -$355.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $2.04M derived: sum of 2 quarters · filed 2021-03-09 | $2.44M derived: sum of 3 quarters · filed 2021-03-09 | $2.69M 10-K · filed 2021-03-09 | |
| 2019-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.79M derived: sum of 2 quarters · filed 2020-11-12 | $3.05M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $403.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $654.00K 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $251.00K 10-Q · filed 2020-05-07 | ||||
| 2018-12-31 | $12.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |